In the complex landscape of cancer biology, the discovery of
microproteins has triggered a paradigm shift, thereby, challenging the
conventional conceptions of gene regulation. Though overlooked for
years, these entities encoded by the small open reading frames (100-150
codons), have a significant impact on various cellular processes. As the
pioneers of precision medicine delve deeper into genome and proteome,
the spotlight now illuminates these small but mighty proteins, which is
characterized by a single protein domain without any functional motifs.
Till date, though only a small subset of them has been characterized, it
has been demonstrated that these microproteins play a key role in
fundamental biological processes such as RNA processing, DNA repair, and
metabolism regulation. Techniques for identification and
characterization such as ribosome profiling and proteogenomic approaches
have unraveled unique mechanisms by which these microproteins regulate
cell signaling or pathological processes against most of the diseases
including cancer. However, the functional relevance of these
microproteins in cancer remains a mystique. In this context, the current
review aims to “rethink the essence genes” and explore “how the
hidden players-microproteins orchestrate the hallmarks and signaling
cascades of cancer, both as accelerators and brakes”.